2014
DOI: 10.1007/s00204-014-1239-1
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial dysregulation and protection in cisplatin nephrotoxicity

Abstract: Nephrotoxicity is a major side effect of cisplatin in chemotherapy. Pathologically, cisplatin nephrotoxicity is characterized by cell injury and death in renal tubules. The research in the past decade has gained significant understanding of the cellular and molecular mechanisms of tubular cell death, revealing a central role of mitochondrial dysregulation. The pathological changes of mitochondria in cisplatin nephrotoxicity are mainly triggered by DNA damage response, pro-apoptotic protein attack, disruption o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
89
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 128 publications
(91 citation statements)
references
References 57 publications
1
89
0
1
Order By: Relevance
“…Apoptosis of tubular epithelial cells contribute to cisplatin-induced AKI, and inhibition of apoptosis may be therapeutic strategy for cisplatin-induced AKI [25, 26]. In the current study, cisplatin significantly increased the number of TUNEL-positive cells in WT mice, which was markedly reduced by disruption of CXCL16.…”
Section: Discussionmentioning
confidence: 52%
“…Apoptosis of tubular epithelial cells contribute to cisplatin-induced AKI, and inhibition of apoptosis may be therapeutic strategy for cisplatin-induced AKI [25, 26]. In the current study, cisplatin significantly increased the number of TUNEL-positive cells in WT mice, which was markedly reduced by disruption of CXCL16.…”
Section: Discussionmentioning
confidence: 52%
“…However, accumulating evidence suggests that DNA damage and the associated DNA damage response (DDR) are the indispensable pathogenic mechanism. p53, a well-known tumor suppressor protein, is considered closely related to DNA damage induced by cisplatin [16]. In 2010, we reported the first evidence of microRNA regulation in cisplatin nephrotoxicity [17].…”
Section: Microrna In Cisplatin Nephrotoxic Akimentioning
confidence: 99%
“…HK-2 cells were treated with SSD (0,20,40,60,80,100 or 150 μM) for 24 h (A) and were then uniformly treated with the maximum dose of SSD (100 μM) for different periods (0, 6, 12, 24 or 48 h; B). The cells were treated with DDP (0, 2.5, 5, 10, 20 or 30 μM) for 24 h (C) and were pretreated with SSD (100 μM) for different periods (0, 15 min, 30 min, 1 h, 2 h, 4 h, 8 h, 16 h or 32 h) and were pretreated with SSD (20,40,60,80,100 or 150 μM) for 2 h and then were treated with 10 μM DDP (E) for 24 h. Cell viability was determined using the CCK-8 assay according to the absorbance value (A). The data are presented as the mean values ± SD from five independent experiments.…”
mentioning
confidence: 99%